Influence of the Brownie Breast Shield on the Dynamics of Milk Removal

NCT ID: NCT03091985

Last Updated: 2020-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-31

Study Completion Date

2017-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the efficacy of breast drainage of the healthy breast with the new Medela pump set breast shield (Brownie).

The objective of the study is to verify the Brownie breast shield to be non-inferior to the current PersonalFit breast shield in emptying the healthy lactating breast.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study we could show that the Brownie shield is non-inferior to the PersonalFit shield in all four endpoints, superior to the PersonalFit shield in terms of PAMR and expressed milk volume, and is more comfortable than the PersonalFit shield according to participant surveys.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lactation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Drainage of the lactating breast using:

PersonalFit - Breast shield \& Brownie - Breast shield

Breast shields are each to be used for 15 min pumping with the symphony breastpump

Group Type EXPERIMENTAL

PersonalFit - Breast shield

Intervention Type DEVICE

Subjects are to pump 15 min with the comparator device

Brownie - Breast shield

Intervention Type DEVICE

Subjects are to pump 15 min with the investigational device

Group B

Drainage of the lactating breast using:

Brownie - Breast shield \& PersonalFit - Breast shield

Breast shields are each to be used for 15 min pumping with the symphony breastpump

Group Type EXPERIMENTAL

PersonalFit - Breast shield

Intervention Type DEVICE

Subjects are to pump 15 min with the comparator device

Brownie - Breast shield

Intervention Type DEVICE

Subjects are to pump 15 min with the investigational device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PersonalFit - Breast shield

Subjects are to pump 15 min with the comparator device

Intervention Type DEVICE

Brownie - Breast shield

Subjects are to pump 15 min with the investigational device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject ≥ 18 years old
2. Infant is ≥1 and ≤6 month old
3. Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
4. The subject agrees to pump or feed the last time a minimum of 3 hours before the start of the pumping session at the study site
5. The subject agrees to photographs of the breast and upper body (no face)
6. The subject agrees to perform a 24 hour milk production at home, inclusive weighing the Infant before and after each feeding
7. The subject agrees to collect \~2 ml of milk before and after each feeding for fat analysis
8. The subject signed the Informed Consent Form

Exclusion Criteria

1. Mastitis (any breast within two weeks prior enrolment)
2. Engorgement (any breast within two weeks prior enrolment)
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinical Trial Unit, University Hospital Basel, Switzerland

OTHER

Sponsor Role collaborator

Medela AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lennart Ivarsson, PhD

Role: PRINCIPAL_INVESTIGATOR

Employee

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medela AG

Baar, Canton of Zug, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Sakalidis VS, Ivarsson L, Haynes AG, Jager L, Scharer-Hernandez NG, Mitoulas LR, Prime DK. Breast shield design impacts milk removal dynamics during pumping: A randomized controlled non-inferiority trial. Acta Obstet Gynecol Scand. 2020 Nov;99(11):1561-1567. doi: 10.1111/aogs.13897. Epub 2020 Jun 5.

Reference Type DERIVED
PMID: 32401335 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MHM1601

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.